This inventor holds 2 USPTO granted patents, plus 3 CIPO patents and 1 EPO patent. Top assignee: Atopix Therapeutics Limited. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Roch Thibert: Innovator in Pharmaceutical Chemistry
Introduction
Roch Thibert is a notable inventor based in Laval, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of 2 patents to his name, Thibert's work is recognized for its potential impact on treatment methodologies.
Latest Patents
Thibert's latest patents include a groundbreaking invention related to a stable amorphous form of (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid. This invention is particularly relevant for its use in treating conditions mediated by the action of PGD at the CRTH2 receptor. The stability of this amorphous form enhances its applicability in therapeutic settings.
Career Highlights
Thibert is currently associated with Atopix Therapeutics Limited, where he continues to push the boundaries of pharmaceutical innovation. His work focuses on creating effective treatments that can significantly improve patient outcomes.
Collaborations
Thibert collaborates with talented professionals in his field, including Aimesther Betancourt and Marc Lemieux. These collaborations foster a dynamic environment for innovation and research.
Conclusion
Roch Thibert's contributions to pharmaceutical chemistry exemplify the spirit of innovation in the medical field. His patents and ongoing work at Atopix Therapeutics Limited highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile